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S everal recent studies have identified an acceleratingrate of radiation exposure in patients with poorly con-
trolled complicated small bowel Crohn’s disease (CD),
largely due to abdominal and pelvic computed tomography
(CT) scans performed in local emergency departments with
potentially long-term clinical consequences.1–3 This has
motivated active research into alternatives for disease activ-
ity assessment, including magnetic resonance enterography
(MRE).
Dr. Siddiki et al designed this study to assess
whether MRE is as accurate as CT enterography (CTE)
in assessing disease activity. They performed clinical
evaluation, ileocolonoscopy, CTE, and MRE in 30
patients (3 were unable to complete all 3 studies). The
radiologist readers were blinded to clinical information
when reading each scan. The interobserver agreement
was substantial for both MRE (0.63, 95% confidence
interval [CI] 0.31–0.92) and for CTE (0.76, 95% CI 0.5–
1.0). MRE had a sensitivity of 90.5% (95% CI 70–99)
and specificity of 66.7% (95% CI 30–93) and CTE had a
sensitivity of 95.2% (95% CI 76–100) and specificity of
88.9% (95% CI 52–100) for detecting small bowel dis-
ease activity. Twenty-three (77%) patients underwent
MRE the same day as the CTE. The remainder underwent
MRE within 21 days of CTE.
The endoscopy was performed without input from
the study team, and therefore no endoscopic disease sever-
ity scoring was performed, and biopsies were not consis-
tently obtained. MRE and CTE scans identified disease ac-
tivity in 8 patients (24%) with normal endoscopy, and in
an additional 3 patients who did not have ileal intubation
on colonoscopy. A composite ‘‘clinical reference standard’’
of active, inactive, or absent small bowel CD was con-
structed based on the impression of the treating clinician,
the findings on endoscopy, biopsies (if taken), and readings
of the CTE and MRE (after they had already been scored).
Twenty-two patients (67%) had active disease, 2 (6%) had
inactive disease, and 9 (27%) had no evidence of CD.
MRE and CTE had similar sensitivities for detecting active
small bowel inflammation.
COMMENT
Dr. Siddiki et al compared CTE and MRE head-to-
head in 30 patients with suspected inflammatory bowel
disease and recent ileocolonoscopy in order to determine
whether MRE is capable of replacing CTE as the diag-
nostic imaging test of choice for CD. Although there is
no single gold standard for disease activity, comparison
with a global clinical impression that takes into account
both endoscopic and clinical as well as imaging findings
is the most practical gold standard for disease activity in
CD.
However, neither the ‘‘comprehensive clinical refer-
ence standard’’ nor the endoscopic and biopsy assessment
were standardized, and the absence of a consistent method
for determining the activity leaves the reliability of this ref-
erence standard shaky. A similar study by Lee et al4 used
more consistent definitions of endoscopic disease severity
and found MRE to be similarly comparable to CTE. Ippo-
lito et al’s5 study used Crohn’s Disease Activity Index
(CDAI) scores as a reference standard and found MRE and
CTE to be fairly similar, with CTE better for fatty prolifer-
ation and MRE better for fistulizing disease.
MRE suffered somewhat in image quality, and did
not provide high-quality images as consistently as CTE.
The use of buscopan in Europe may substantially improve
the quality of MRE by limiting peristalsis, but buscopan is
not available in the US.6 Quality improvement initiatives at
our center are actively trying to identify combinations of
glucagon with other medications to replicate the effects of
buscopan. MRE trended toward a lower specificity for dis-
ease activity versus CTE, without reaching statistical sig-
nificance. The interobserver agreement of the various spe-
cific imaging features of MRE and CTE were good, but it
remains to be seen how consistent radiologic readings will
be outside of academic centers. The 1 comparison that may
be clinically significant was that MRE had a substantially
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higher kappa score for penetrating disease than CTE. This
would imply that MRE is more consistently able to detect
penetrating disease than CTE, a feature that has been sug-
gested in other studies.5,7
Despite the limitations of this small study, it does
show roughly similar accuracy of MRE and CTE in
patients with suspected small bowel CD, consistent with
other comparative studies. Five immediate issues remain
unaddressed. Can MRE motion artifact be reduced and
image quality be improved? Can these scans predict clini-
cal outcomes? Can the cost be reduced? Can this accuracy
be replicated outside of academic centers? And will MRE
be accurate in children, who are inherently more suscepti-
ble to ionizing radiation?1–3 At this point, MRE appears
comparable to CTE, although it might have slightly less
specificity for disease activity. In patients who have com-
plicated small bowel CD at centers with expertise in MRE,
the choice of MRE trades a small loss of specificity and
increased cost for the elimination of radiation exposure. In
patients with complicated small bowel CD, this can often
be a worthwhile tradeoff.
Jeremy Adler, MD
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